AEON Biopharma

Filed a patent for "glp1 agonists and treatment of headache disorders" on Mon, November 7, 2022

Filed a patent for "neurotoxin compositions for use in treating headache" on Fri, August 25, 2023

Filed a patent for "neurotoxin compositions for use in treating headache" on Thu, February 15, 2024

Filed a patent for "single-use neurotoxin formulations and packaging" on Thu, February 8, 2024

Filed a patent for "neurotoxin compositions for use in modulating stellate ganglion activity" on Fri, April 15, 2022

Filed a patent for "neurotoxin compositions for use in regulating brain temperature" on Fri, April 15, 2022

Filed a patent for "neurotoxin compositions for use in treating cardiovascular disorders" on Thu, May 11, 2023

Filed a patent for "neurotoxin compositions for use in treating gastroparesis" on Thu, October 20, 2022